Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Having enough money to get through Clinicals Can't be all bad.
Doing that on the NASDAQ is a Plus!!!
Soon we Shine!!
$$$SBFM$$$
This Quiet Period!!
Yea I remember the Experts Saying that to.
So many experts here.
Yea S&P -2.24 NAZ -2.59 DJIA -1.87
This will be the Talk of NASDAQ Soon. Book It!
Univ AZ is an Addition, just like UGA failed Drug was.
SBFM intends to Put a Drug on the Market or OWN the PLPro Space.
But if it didn't fail you don't want to be a competitor later.
If one fails in human, there is a backup. If all pass there is no room for anyone in PLPro.
Why leave a competitor to compete.
BTW Slilaty is not New TO Univ AZ considering that's the Same Dept he got is PHD from.
Anyway no need to post again I will not be responding. Tired of the Negativity, I know what I own.
BAAAAA HHAHA!!! I told the Bozoos here Month ago, Pegan Never left the Drug, His main part of the work was done, his lab moved but that obviously won't stop him from getting some credit in SBFM-PL4.
I thank the Study released this week is progression and Material.
That I doubt.
Next week we get Material Events for Sure.
SBFM will Own the PLpro Space if all works out.
Ok have it your way, Sunshine releases a PR about the effectiveness of PL4 before Results by the Researchers are Published.
And if effective the OWN the PLpro Space.
Update on SBFM-PL4 not Possible until results are Published.
Maybe tomorrow morning. Maybe Monday. Let's See.
I am not going anywhere anytime soon. The Negativity was more than I could bare.
My feeling is its time for the Company to Speak and I am sure they will. Otherwise, after more than a Year, Enough Said.
It you are long this stock, don't be discouraged I can smell a Big PR soon that's not like the others.
My only hope is that it moves the market as we hope.
$SBFM for the Win, and Soon.
He still has controlling interest.
Stated in the Filing Quote
Have a good Weekend.
It's a precursor to a buy before Mega News! Book It
They will buy, the form is a buy signal. Buy Incoming.
NOOO they don't have any. That was Tensley and the guy that got Booted.
Form says Zero, required. for both.
Another Board Member and Likely another one Scammed.
Or Just Buying for the Heck of it.
Or has another person been scammed?
Looks like we got some Insider Buying?? No?? Form Three
Form 3 is an SEC filing filed with the US Securities and Exchange Commission to indicate a preliminary insider transaction by an officer, director, or beneficial (10%) owner of the company's securities. These are typically seen after a company IPOs when insiders make their first transactions. After a Form 3 is filed, future filings of the same nature are filed under Form 4 (standard disclosure ...
Float Started with 550 Million Pre-Split. You tell meish.
LOL
Oh ok thanks for your insight. Alternative is Float is gonish..
Hello anybody know, Where the Volume?
I agree but not like you think.
SMH!! We get all kinds on the board trying to make $SBFM Great Again. Soon!!
One Dump on Uplist in the first 60 mins
Sideways for 4 days on 1 Billion pre slip Vol.
If news drops this morning or Monday, you might be running after that A$$, they owe us that.
If the news is Weak, we have not seen the bottom.
This CEO loves to party Especially a lil A$$ Slapping.
The more you Slap that $SBFM Ask the drunker he gets.
Sure Is!!
Already a Millionaire (See For Yourself)
Dr. Steve N. Slilaty, Ph.D. serves as a Chairman of the Board, President, Chief Executive Officer of Sunshine Biopharma, Inc., since October 15, 2009.
In addition, since February 2002, Dr. Slilaty has been President and Chief Scientific Officer of Advanomics Corporation, Montreal, Canada, a privately held company engaged in the research, development and commercialization of drugs for the treatment of various forms of cancer. Advanomics Corporation is the third in a line of biotechnology companies that Dr. Slilaty founded and managed through their early and mid-stages of development.
The first, Quantum Biotechnologies Inc. later known as Qbiogene Inc., was founded in 1991 and grew to over $60 million in annual sales. Today, Qbiogene is a member of a family of companies owned by MP Biomedicals, one of the international suppliers of biotechnology reagents with a catalogue containing over 55,000 products.
The second company which Dr. Slilaty founded, Genomics One Corporation, now known as Alert B&C Corporation, conducted an initial public offering (IPO) of its capital stock in 1999 and, on the basis of its ownership of
Dr. Slilaty’s patented TrueBlue® Technology, Genomics One became one of the handful of participants in the Human Genome Project. Formerly a research team leader of the Biotechnology Research Institute, a division of the National Research Council of Canada, Dr. Slilaty also served as a consultant in a management and advisory capacity for a Canadian biotechnology company between 1995 and 1997 during which time the company completed one of the biotechnology IPO‘s in Canada raising over $34 million.
Dr. Slilaty received his Ph.D degree from the University of Arizona in 1983 and a Bachelor of Science degree from Cornell University in 1976.
We all have the Option to Put Our Money where our Mouth Is.
My Money is on $SBFM for the WIN!!
Who cares Keep on Tracking But. My guess is your time is wasted.
LOLOLOL You got out before the Fake News Right!!
Slilaty was already a multimillionaire before SBFM FACT.
Just from his Video interview you would not even know.